vimarsana.com

Page 112 - நோய் எதிர்ப்பு சக்தி பாதுகாப்பு ப்ரோடீந்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gut Microbiota Reflects Disease Severity in COVID-19 Patients

Gut Microbiota Reflects Disease Severity in COVID-19 Patients Compared with non-COVID-19 patients, those with COVID-19 showed a substantially changed gut microbiome, whether or not they received medication.  Caption: Image: CC BY 2.0 Go-tea 郭天 Celiac.com 03/15/2021 - COVID-19 is mainly a respiratory illness, but there is mounting evidence to indicate that the gut and gut microbiota may play a role in the disease. A team of researchers recently set out to determine if the gut microbiome is linked to disease severity in patients with COVID-19, and whether variations in microbiome composition might resolve with the passing of the SARS-CoV-2 virus. The research team included Yun Kit Yeoh, Tao Zuo; Grace Chung-Yan Lui; Fen Zhang; Qin Liu; Amy YL Li; Arthur CK Chung; Chun Pan Cheung; Eugene YK Tso; Kitty SC Fung; Veronica Chan; Lowell Ling; Gavin Joynt; David Shu-Cheong Hui; Kai Ming Chow; Susanna So Shan Ng; Timothy Chun-Man Li; Rita WY Ng; Terry CF Yip; Grace Lai-Hung Wong; F

Russia extends ban on UK flights by a month over coronavirus variant

MOSCOW (Reuters) - Russia has extended a ban on flights to and from Britain by one month up to April 16 due to a variant of the coronavirus first detected in the UK, Russia s coronavirus task force said on Tuesday. Russia, which has had the flight ban in place since Dec. 22, reported 28 cases of the more infectious coronavirus variant on Tuesday, consumer health regulator Rospotrebnadzor said. To ensure the protection of public health, the restrictions have been extended until 2359 (2059 GMT) on April 16, 2021, the coronavirus task force said in a statement. Kremlin spokesman Dmitry Peskov said earlier on Tuesday that the situation with COVID-19 was more tense in Europe than in Russia. In Europe the situation is unstable, we have a more optimistic picture, which however does not give us the chance to relax, Peskov told reporters on a conference call. Shop closures, curfews and bans on non-essential travel are in place in many European countries, whereas Russia has lifted most of its co

WHO: Smoking doubles sudden infant death and birth defects

Date Time WHO: Smoking doubles sudden infant death and birth defects A new WHO report, Tobacco Control To Improve Child Health And Development, calls for raising awareness among practitioners and policymakers about the importance of strong tobacco control measures for protecting the health and development of children. These include banning tobacco advertising, implementing 100% smoke-free environments and raising taxes on tobacco. Exposure to tobacco smoke has devastating impacts throughout childhood and adolescence, starting from conception. Exposure of unborn children to maternal smoking or second-hand smoke is linked to birth defects, stillbirths, preterm births and infant deaths. Maternal smoking during pregnancy is linked to a doubling of the risk of sudden infant death and birth defects, while exposure to second-hand smoke during pregnancy is linked to a 23% increased risk of stillbirth and 13% increased risk of congenital malformation.

CDC blurs geography in reporting COVID-19 deaths, researchers say

Global Rare Disease Diagnostics Market to Reach $70 69 Billion by 2030, as per BIS Research Study

(1) FREMONT, Calif., March 16, 2021 /PRNewswire/ The premium market intelligence report published by BIS Research on the Global Rare Disease Diagnostics Market highlights that the market is projected to reach $70.69 billion by 2030. The study also highlights that the market is set to witness a CAGR of 8.57% during the forecast period, 2020 and 2030, aided primarily by the impressive growth in the underlying services market. The comprehensive study covers the following: Market numbers on micro-segments that are influencing the market? More than 200 products present in the market Market share analysis for more than 15 companies and study of data of more than 30 companies End user preference data for over 20 end-users

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.